Nikolaj Bak
Overview
Explore the profile of Nikolaj Bak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Siskind D, Hahn M, Correll C, Fink-Jensen A, Russell A, Bak N, et al.
Diabetes Obes Metab
. 2018 Sep;
21(2):293-302.
PMID: 30187620
Aims: To evaluate if glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce antipsychotic-associated body weight gain in patients with schizophrenia, when compared to controls. Materials And Methods: We systematically searched PubMed/EMBASE/PsycINFO/Cochrane using...
12.
Jessen K, Rostrup E, Mandl R, Nielsen M, Bak N, Fagerlund B, et al.
Psychol Med
. 2018 May;
49(5):754-763.
PMID: 29734953
Background: Schizophrenia has been associated with changes in both cortical thickness and surface area, but antipsychotic exposure, illness progression and substance use may confound observations. In antipsychotic-naïve schizophrenia patients, we...
13.
Ebdrup B, Broberg B, Ishoy P, Bak N, Andersen U, Jorgensen N, et al.
Diabetes Obes Metab
. 2018 Jan;
20(5):1327-1328.
PMID: 29316175
No abstract available.
14.
Glenthoj L, Fagerlund B, Bak N, Hjorthoj C, Gregersen M, Kristensen T, et al.
Schizophr Res
. 2017 Nov;
195:562-563.
PMID: 29102222
No abstract available.
15.
Hass K, Bak N, Szycik G, Glenthoj B, Oranje B
Biol Psychol
. 2017 Jul;
128:112-116.
PMID: 28754277
Objectives: To investigate whether the typically reported deficient sensorimotor gating in patients with schizophrenia using unimodal paradigms can also be detected by a cross-modal paradigm which made use of an...
16.
Glenthoj L, Fagerlund B, Hjorthoj C, Jepsen J, Bak N, Kristensen T, et al.
Schizophr Res Cogn
. 2017 Jul;
5:21-27.
PMID: 28740813
Objective: Patients at ultra-high risk (UHR) for psychosis show significant impairments in functioning. It is essential to determine which factors influence functioning, as it may have implications for intervention strategies....
17.
Axelsen M, Jepsen J, Bak N
Biol Psychiatry
. 2017 Jul;
83(12):e59-e60.
PMID: 28688580
No abstract available.
18.
Bak N, Hansen L
PLoS One
. 2016 Oct;
11(10):e0164464.
PMID: 27723782
Missing data is a common problem in many research fields and is a challenge that always needs careful considerations. One approach is to impute the missing values, i.e., replace missing...
19.
Ishoy P, Knop F, Broberg B, Bak N, Andersen U, Jorgensen N, et al.
Diabetes Obes Metab
. 2016 Oct;
19(2):162-171.
PMID: 27717222
Aims: Schizophrenia is associated with cardiovascular co-morbidity and a reduced life-expectancy of up to 20 years. Antipsychotics are dopamine D receptor antagonists and are the standard of medical care in...
20.
Coello K, Broberg B, Bak N, Madsen A, Mortensen H, Sogaard B, et al.
Psychoneuroendocrinology
. 2015 Jun;
60:1-6.
PMID: 26094073
Introduction: Hyperprolactinemia is a common side-effect of antipsychotic treatment. Antipsychotics and hyperprolactinemia are both considered risk factors of metabolic disturbances and diabetes. Investigations on prolactin response to meal ingestion in...